Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{158201,
        author = {B Ashok and Navaneeth J and Rahul C},
        title = {Comparative analysis of Indian pharmaceutical companies during Covid},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {9},
        number = {9},
        pages = {163-169},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=158201},
        abstract = {The coronavirus pandemic's effects on India have primarily disrupted economic activities and resulted in fatalities. Almost every industry has suffered as domestic demand and exports have dramatically decreased, with some notable outliers where strong growth has been seen. Analysis of the effects and potential remedies for several important industries is attempted.
Since the Covid-19 pandemic began, the pharmaceutical business has grown, particularly in India, the world's top producer of generic medications. In the beginning of 2020, it had a market of $55 billion and was booming in India, supplying hydroxychloroquine to countries all over the world, including the US, UK, Canada, and the Middle East.},
        keywords = {},
        month = {},
        }